Stockholm · Seed–Growth · 30 people tracked
Also known as HEALTHCAP ADVISOR AB · HEALTHCAP IX ADVISOR AB · HEALTHCAP VII ADVISOR AB · HEALTHCAP VIII ADVISOR AB
Investment thesis
HealthCap invests in and helps build life science companies developing breakthrough therapies with a high unmet medical need. It focuses on emerging therapeutics, particularly targeted treatments for rare diseases, cancers, and genetic diseases. The firm emphasizes deep medical expertise across medicine, finance, and biochemistry, and aims to challenge existing medical paradigms to find new ways to treat or cure diseases and improve quality of life. HealthCap stresses a responsible and sustainable approach to investing and ownership, collaborating with investors, academia, portfolio companies, patients, and other societal stakeholders to create long-term value and positive impact.
Source: firm website, verified Aug 25, 2026.
Team · 30 people
from the firm's website & curated & public directories
What they invest in
from 30 of 35 portfolio companiesBiotech ×25Healthtech ×24Medical Devices ×16Digital Health ×7Deep Tech ×4Hardware ×2AgTech ×1AI & Machine Learning ×1
HQs:United States×9Sweden×8Switzerland×1Finland×1France×1United Kingdom×1
Who they back
founder profiles across 13 portfolio companiesFounding team size:solo founder×62 founders×43 founders×14+ founders×2
Investments · 35 tracked
founders shown can be your intro pathBy year:2025 · 22020 · 22017 · 12015 · 27 dated
Pulmonx develops the Zephyr Valve, a bronchoscopic device used to treat patients with severe COPD/emphysema without surgery.
BiotechHealthtechMedical DevicesSan Jose, US
GLENDON E. FRENCH(Executive Officer, Director)LAUREN CRISTINA(Executive Officer)inSri Radhakrishnan(Chief Technology Officer)inMICHAEL BAKER(Executive Officer, Director)in
BoardDANA G. MEAD, JR(Director)STEPHEN SALMON(Director)in
Board seatStaffan Lindstrand· per SEC Form D
Co-investorsBand of AngelsKaiser Permanente VenturesLatterell Venture Partners
Spruce Biosciences develops and commercializes therapies for serious neurological and endocrine disorders with unmet medical need, with a lead investigational enzyme replacement therapy (TA-ERT) for Mucopolysaccharidosis Type IIIB (Sanfilippo Syndrome Type B).
BiotechHealthtechSouth San Francisco, US
Javier Szwarcberg(Executive Officer, Director)inSamir Gharib(Executive Officer)inRICHARD KING(Executive Officer, Director)in
BoardSimpson Camilla(Director)Tiba Aynechi(Director)inBali Muralidhar(Director)in
Board seatJonas Hansson· per SEC Form D
Co-investorsAisling CapitalRiverVest Venture PartnersAbingworthNorwest Venture PartnersOrbiMed
BiotechDoylestown, US
John P. Hamill(Executive Officer)Oren Gilad(Executive Officer, Director)
BoardJean-Pierre Bizzari(Director)Gabriela Gruia(Director)Rifat Pamukcu(Director)Bernd Seizinger(Director)
Hemab develops targeted therapies for bleeding and clotting disorders such as Glanzmann thrombasthenia, Factor VII deficiency, Von Willebrand Disease, and heavy menstrual bleeding.
BiotechDigital HealthHealthtechMedical Devices
Co-investorsAccess BiotechnologyAvoro Capital AdvisorsNovo HoldingsSofinnova Partners
Doctrin provides a digital communication platform for healthcare providers to manage patient interactions and case management, including medical history taking, triage, collaboration tools, and chat/video capabilities.
Digital HealthEnterprise SoftwareHealthtechSaaSStockholm, GB
Oncorena is a Swedish pharmaceutical company developing a breakthrough treatment for metastatic renal cancer based on the drug candidate ONC175 (orellanine).
BiotechHealthtechMedical DevicesStockholm, SE
Börje Haraldsson(Research lead)Jenny NyströmUlf NilssonLisa BuvallPål FalckSusanna Dahlgren(Chief Operating Officer)
Co-investorsFSG
SynOx Therapeutics develops emactuzumab, a monoclonal antibody treatment for tenosynovial giant cell tumours (TGCT) and macrophage-mediated diseases.
BiotechHealthtechMedical Devices
Ray Barlow(Chief Executive Officer)
Co-investorsBioqube VenturesForbion
Tribune Therapeutics is a preclinical biopharmaceutical company developing medicines that target CCN protein family signaling (such as CCN2/CTGF) to block fibrotic pathways.
BiotechHealthtech
Ole Kaasbøll(Co-founder)
Co-investorsIndustrifondenLifeArc VenturesInvestinorNovo Holdings
Vivet Therapeutics is a clinical-stage biotechnology company developing recombinant adeno-associated virus (rAAV) gene therapies for rare, inherited metabolic diseases, including Wilson's Disease and cerebrotendinous xanthomatosis.
BiotechHealthtechParis, FR
Co-investorsKurma PartnersNovartis Venture FundRoche Venture FundYsios CapitalColumbus Venture PartnersEurazeo+1 more
Incardatherapeutics develops drug therapies for treating atrial fibrillation using synergistic combinations of anti-arrhythmic agents, with delivery platforms designed for both hospital and at-home settings.
BiotechDigital HealthMedical DevicesBrisbane, US
Carlos A. Schuler(Executive Officer, Director)John S. Patton(Executive Officer, Director)Rangachari Narasimhan(Executive Officer, Director)Grace Colon(Executive Officer, Director)Miller Samantha(Executive Officer)
BoardMcCarthy Reenie(Director)
Board seatJohan Christenson· per SEC Form D
Co-investorsAsset Management CompanySofinnova VenturesDeerfield Management Company
BiotechRaleigh, US
Jaikrishna Patel(Executive Officer)Pierre Legault(Executive Officer, Director)James Mitchum(Director)John Hamill(Executive Officer)
BoardRobert Seltzer(Director)
Board seatEugen Steiner· per SEC Form D · $28.5M raise · filed Nov 2015
Adcendo develops antibody-drug conjugates (ADCs) targeting cancers with high unmet medical need.
BiotechMedical Devices
Co-investorsVida VenturesJeito CapitalNovo HoldingsOrbiMedPontifax Venture CapitalRA Capital+2 more
AMRA Medical is a global health informatics company specializing in MRI-based fat distribution and muscle composition analysis for precision medicine applications.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLinköping, SE
Magnus Borga(Co-Founder)Olof Dahlqvist Leinhard(Chief Executive Officer, Co-Founder)
Co-investorsPfizer Venture Investments
RxList is an online medical resource providing detailed pharmaceutical information on brand and generic drugs, written and reviewed by pharmacists and physicians.
Digital HealthHealthtechMedia & EntertainmentSan Clemente, US
Co-investorsAndera Partners
Aro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins.
BiotechHealthtechPhiladelphia, US
Susan B Dillon(Executive Officer, Director)Karyn O'Neil(Executive Officer, Director)Susan Dillon(Founder)Mark V. Laurenzi(Executive Officer)
BoardElizabeth Anderson(Director)Bruce Peacock(Director)
Co-investorsAvego BioScience CapitalAgent Capital
BoneSupport develops synthetic bone graft substitutes that remodel to match patient bone and elute antibiotics to prevent infection during healing.
BiotechHealthtechMedical Devices
Co-investorsIndustrifonden
CAR-Macrophage cellular therapeutics with initial oncology focus (NASDAQ: CARM).
BiotechPhiladelphia, US
Steven Kelly(Executive Officer, Director)
BoardMargarita Chavez(Director)Eran Nadav(Director)Althea Stillman(Director)Jacob Gunterberg(Director)Regina Hodits(Director)
Co-investorsAju IB Invesment CorporationAnzu PartnersGrazia Equity GmbHMRL Ventures FundSolasta VenturesAgent Capital+1 more
CurifyLabs develops an automated compounding system for pharmacies that uses robotics, GMP-manufactured excipient bases, and integrated quality control software to enable faster, safer preparation of customized medications.
Digital HealthHealthtechMedical DevicesHelsinki, FI
Charlotta TopeliusNiklas Sandler Topelius
Co-investorsLifeline VenturesSandwater
Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells.
BiotechHealthtech
Co-investorsFACIT (Fight Against Cancer Innovation Trust)Lumira VenturesSeroba Life SciencesVenture OntarioYsios CapitalAdams Street Partners+2 more
Gesynta Pharma develops pharmaceutical treatments for inflammation and pain by selectively inhibiting the enzyme mPGES-1.
BiotechDigital HealthFemTechStockholm, SE
Patric Stenberg(Founder)Gunilla Ekström(Founder)in
Co-investorsAmboy Street VenturesCatalyze CapitalForeground CapitalHadean VenturesIndustrifondenXGEN Venture
Co-investorsCrane Venture Partners
Kivu Bioscience develops antibody-drug conjugate (ADC) therapeutics in clinical development, advancing a pipeline of cancer treatments through strategic partnerships and collaborations.
BiotechDeep TechHealthtechMedical Devices
Mohit Trikha(CEO)Sophia Randolph(Chief Medical Officer)
Co-investorsBOMM VenturesRed Tree VentureBioGeneration VenturesNovo Holdings
Mahzi develops therapies for patients with under-diagnosed and under-served rare genetic neurodevelopmental disorders, working with patient and family groups, academic researchers, and industry partners.
BiotechHealthtechSouth San Francisco, US
Yael Weiss(Executive Officer, Director)in
BoardCamille Samuels(Director)inMarten Steen(Director)inShalini Sharp(Director)inStephen Farr(Director)
Co-investorsDroia VenturesMitsui Global InvestmentVenrockVenrock Associates
Neobiomics develops multi-strain food supplements rooted in academic research, with collaborations across Europe.
BiotechFoodTechHealthtechMedical DevicesWellness & FitnessStockholm, SE
Philipp Novak(Co-founder)Stefan Johansson(MD PhD, CMO)
Oncopeptides develops cancer therapies based on proprietary Peptide Drug Conjugate (PDC) and SPiKE technology platforms, targeting rare hematological diseases such as multiple myeloma.
BiotechHealthtech
Co-investorsIndustrifonden
Positrigo develops functional imaging technology to make diagnostic and clinical imaging scalable and accessible globally.
Deep TechHardwareHealthtechMedical Devices
Co-investorskineo finance
Co-investorsBioMedPartnersPontifax Venture CapitalV-Bio VenturesInkef
Pretzel Therapeutics develops therapeutics targeting bioenergetic dysfunction and mitochondrial disease by addressing defects in mitochondrial DNA function and gene expression.
BiotechDeep TechHealthtechMedical Devices
Michal Minczuk(Co-Founder)Gabriel Martinez(Chief Scientific Officer & Co-Founder)Claes Gustafsson(Co-Founder)Maria Falkenberg(Co-Founder)Nils-Göran Larsson(Co-Founder)Jay Parrish(Chief Executive Officer & Chairman of the Board)in
Co-investorsARCH Venture PartnersCambridge Innovation CapitalEIR VenturesGV (Google Ventures)
Priothera is a clinical-stage biopharmaceutical company developing mocravimod, an investigational immune modulator intended as a maintenance therapy for allogeneic hematopoietic cell transplantation.
BiotechHealthtech
Florent Gros(Founder & CEO)
Co-investors4see VenturesFountain Healthcare Partners
Vicore Pharma is a clinical-stage biopharmaceutical company developing disease-modifying treatments for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis.
BiotechHealthtechMedical Devices
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 4
IPOs and acquisitions across the tracked portfolioPulmonx Corp.NASDAQ: LUNGSpruce BiosciencesNASDAQ: SPRBAprea TherapeuticsNASDAQ: APREHemab TherapeuticsNASDAQ: COAG
Portfolio news
latest coverage across their companiesSpruce Biosciences · stocktitan.net · Aug 14, 2026
Aprea Therapeutics · tradingview.com · Aug 12, 2026
Pulmonx Corp. · defenseworld.net · Jul 19, 2026
Adcendo ApS · geekwire.com · Jul 13, 2026
Mahzi Therapeutics · forbes.com · Jul 13, 2026
CurifyLabs · mobihealthnews.com · Jul 7, 2026
Carisma Therapeutics · bizjournals.com · Dec 16, 2025
Pretzel Therapeutics · nasdaqprivatemarket.com · Aug 3, 2025
Frequently asked questions
- How many investments has HealthCap made?
- HealthCap has 34 tracked investments, including 2 dated in the last 24 months.
- What stage does HealthCap invest at?
- HealthCap invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does HealthCap focus on?
- HealthCap focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is HealthCap located?
- HealthCap is headquartered in Stockholm, SE.
- Who does HealthCap co-invest with?
- HealthCap most often shares deals with Industrifonden, Novo Holdings, Pfizer Venture Investments, among 58 tracked co-investors.
Media · Podcasts & interviews
featuring the teamHealthcare Direkt v.49: Varför är styrelsen viktig? Gäst: Staffan Lindstrand, Partner Healthcap
Direkt Studios · Staffan Lindstrand
Images
Co-investors · 11
Ysios Capital is a life sciences investor that finances innovative biotech companies worldwide, providing resources to develop novel therapies for indications with high unmet medical needs.
Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
ARCH Venture Partners is a venture capital firm that invests in and helps build transformational companies, with a strong focus on the life sciences and biotechnology sector.
RA Capital is a multi-stage investment firm focused on healthcare, life sciences, and planetary health, investing across public and private markets and creating new companies through its Raven incubation platform.
Cambridge Innovation Capital (CIC) is a UK-based venture capital firm backing entrepreneurs in life sciences and deep tech, leveraging its position in the Cambridge science and technology ecosystem.
Abingworth is a life science venture capital firm that backs early-stage biopharma and biotech companies, helping entrepreneurs translate scientific discoveries into new therapeutics.
Vida Ventures is a life sciences venture capital firm focused on transforming biomedical innovations into therapies that improve patients' lives.
Earlybird Venture Capital is a European venture capital investor that backs early-stage technology founders with capital, strategic support, and access to an international network.
Pureos Bioventures is a venture capital firm that invests in private, innovative drug development companies, with a focus on next-generation biological drugs and drug formats to treat severe diseases.
Firms observed investing alongside HealthCap, from public investor directories. Shared companies are the overlap with HealthCap's recorded portfolio.
Similar investors
Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.
Hadean Ventures is a European venture capital fund manager with a track record in life sciences, investing across sectors and stages in science-driven innovation addressing real-world challenges.
Alta Partners is a venture capital firm focused on the healthcare and life sciences sector, backing entrepreneurs building companies across biotechnology, therapeutics, and healthcare innovation.
Sciety (Sciety Venture Partners) is a Nordic investment firm that lets its members co-invest alongside it in life science and digital health companies, leading deals from initial dialogue through to funding.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.